New Ranking Highlights NIH’s Impact on Breakthrough Science at Duke Pathology
Duke Pathology received more than $13 million in research funding from the National Institutes of Health (NIH) in 2025, with Duke University School of Medicine r
Dr. John Toffaletti Co-Authors Landmark Study Showing How Shunt Valve Equations are Calculated
Duke Pathology Professor John Toffaletti, PhD, co‑authored a study titled
From Brain Tissue to Blood Tests: Dr. Shih-Hsiu "Jerry" Wang's Research Featured as Translational Science Case Study
Given recent successful developments in treatment for early-stage Alzheimer’s disease, there is a need for tests that allow early diagnosis and prognosis assessment. Duke Pathology's Shih-Hsiu “Jerry” Wang, MD, PhD, and NCCU's Bin Xu, PhD, partnered to conduct research to develop minimally invasive tests for earlier disease diagnosis and monitoring severity
Duke Pathology Faculty Members and Trainees Serve as Editors and Authors of Upcoming Mesothelioma Book
Duke Pathology’s Elizabeth N.
AI ‘Bottleneck’: Putting the Algorithms to Work
Duke pathologists Dr. Carolyn Glass and Dr. William Jeck are addressing critical bottlenecks slowing AI adoption in clinical practice. Their work is highlighted in the January issue of CAP Today magazine in an article.
Dr. Karra Jones Contributes to Multi-Institution Effort Setting Modern Standards for Pediatric Muscle Biopsies
Associate Professor Karra Jones, MD, PhD
Dr. Yiping He Receives Mike Slive Foundation Award to Fund Prostate Cancer Research
In December 2025, the Mike Slive Foundation awarded a research grant to Associate Professor Yiping He, PhD
